Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore

被引:8
|
作者
Hackman, Jada [1 ]
Falade-Nwulia, Oluwaseun [2 ]
Patel, Eshan U. [3 ]
Mehta, Shruti H. [2 ]
Kirk, Gregory D. [2 ,4 ]
Astemborski, Jacquie [2 ]
Ray, Stuart C. [4 ]
Thomas, David L. [2 ,4 ]
Laeyendecker, Oliver [1 ,2 ,4 ]
机构
[1] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Hepatitis C virus; 1CE; Phylogenetic; Molecular epidemiology; PWID; Injection drug use; HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; HCV INFECTION; NEW-YORK; TRANSMISSION; USERS; HIV; PREVALENCE; VANCOUVER; NETWORK;
D O I
10.1016/j.meegid.2019.104078
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study examines correlates of hepatitis C virus (HCV) genetic clustering among community-recruited people who inject drugs enrolled in the AIDS Linked to the IntraVenous Experience cohort in Baltimore between 1988 and 1989. HCV RNA was extracted and the core/envelope-1 region was sequenced. Clusters were identified from maximum likelihood trees with 1000 bootstrap replicates using a 70% aLRT and a 4% genetic-distance threshold in Cluster Picker. Overall, 46% of participants were in a cluster, including 122 genotype-1a and 36 genotype-1b clusters with an average of 2-3 genetically linked HCV infections. The largest cluster consists of 9 participants. In univariable analysis, black race (PR= 1.66 [95% CI: 1.12-2.45]), age < 35 years (PR= 1.18 [95% CI: 1.02-1.37]), and injection drug use of cocaine alone (PR= 1.30 [95% CI: 1.02-1.65]) were significantly associated with being in a cluster. Conversely, a history of medication-associated treatment (MAT) was negatively associated with being in a cluster (PR= 0.82 [95% CI: 0.71-0.95]). In multivariable analysis, black race (APR = 1.62 [95% CI: 1.11-2.38]) remained independently associated being in a cluster while MAT (APR = 0.85 [95% CI: 0.74-0.99]) remained negatively associated with clustering. Our findings suggest strong locally-propagated transmission networks during the early epidemic that was driven by younger PWID. In light of the current opioid epidemic in the US, these findings suggest an urgent need for preventive interventions to mitigate the growth of large HCV transmission networks.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
    Oluwaseun Falade-Nwulia
    Jada Hackman
    Shruti H. Mehta
    Sean D. McCormick
    Gregory D. Kirk
    Mark Sulkowski
    David Thomas
    Carl Latkin
    Oliver Laeyendecker
    Stuart C. Ray
    BMC Infectious Diseases, 20
  • [2] Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
    Falade-Nwulia, Oluwaseun
    Hackman, Jada
    Mehta, Shruti H.
    McCormick, Sean D.
    Kirk, Gregory D.
    Sulkowski, Mark
    Thomas, David
    Latkin, Carl
    Laeyendecker, Oliver
    Ray, Stuart C.
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [3] Phylogenetic clustering of hepatitis C virus infection among people who inject drugs in Baltimore
    Falade-Nwulia, Oluwaseun
    Hackman, Jada
    Mehta, Shruti
    Sulkowski, Mark
    Latkin, Carl
    Thomas, David
    Downing, Zach
    Latanich, Rachel
    Kirk, Gregory
    Laeyendecker, Oliver
    Ray, Stuart
    VIRUS EVOLUTION, 2019, 5 : S7 - S7
  • [4] Population level diversification of hepatitis C viral strains over time among people who inject drugs in Baltimore, MD
    Hackman, J.
    Falade-Nwulia, O.
    Mehta, S.
    Downing, Z.
    Kirk, G.
    Ray, S.
    Thomas, D.
    Laeyendecker, O.
    VIRUS EVOLUTION, 2019, 5 : S7 - S8
  • [5] WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs Comment
    Walsh, Nick
    Verster, Annette
    Rodolph, Michelle
    Akl, Elie A.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (03) : 363 - 371
  • [6] Phylogenetic Clustering of Hepatitis C Virus Among People Who Inject Drugs in Vancouver, Canada
    Jacka, Brendan
    Applegate, Tanya
    Krajden, Mel
    Olmstead, Andrea
    Harrigan, P. Richard
    Marshall, Brandon D. L.
    DeBeck, Kora
    Milloy, M. -J.
    Lamoury, Francois
    Pybus, Oliver G.
    Lima, Viviane D.
    Magiorkinis, Gkikas
    Montoya, Vincent
    Montaner, Julio
    Joy, Jeffrey
    Woods, Conan
    Dobrer, Sabina
    Dore, Gregory J.
    Poon, Art F. Y.
    Grebely, Jason
    HEPATOLOGY, 2014, 60 (05) : 1571 - 1580
  • [7] GLOBAL GENOTYPE DISTRIBUTION OF HEPATITIS C VIRAL INFECTION AMONG PEOPLE WHO INJECT DRUGS
    Bielen, R.
    Robaeys, G.
    Azar, D. G.
    Razavi, H.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S522 - S523
  • [8] Global genotype distribution of hepatitis C viral infection among people who inject drugs
    Robaeys, Geert
    Bielen, Rob
    Azar, Darush Ghezel
    Razavi, Homie
    Nevens, Frederik
    JOURNAL OF HEPATOLOGY, 2016, 65 (06) : 1094 - 1103
  • [9] Hepatitis C Virus Vaccines Among People Who Inject Drugs
    Cox, Andrea L.
    Thomas, David L.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 : S46 - S50
  • [10] Hepatitis C prevalence among people who inject drugs in Hungary
    Gyarmathy, V. Anna
    Sarosi, Peter
    LANCET INFECTIOUS DISEASES, 2015, 15 (11): : 1261 - 1262